2[1]Pablos-Mendez A, Raviglione MC, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance. 1994-1997. World Health Organization-International Union against Taberculosis and Lung disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance[J]. N Engl J Med, 1998,338:1641-1649 被引量：1
3[2]Lambregts-van Weezenbeek KS, Reichman LB. DOTS and DOTS-PLUS: What's in a name[J]. Int J Tuberc Lung Dis,2000,4: 995-996 被引量：1
4[3]Bastan I, Colebunders R. Treatment and prevention of multidrugresistant tuberculosis[J]. Drugs, 1999,58 :633-661 被引量：1
5[4]WHO-IUATLD Globe Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world, report no. 2: prevalence and trends[R]. Geneva: WHO,2000 被引量：1
6[5]World Health Organization. Global tuberculosis control[R].WHO report 2000. Genera:WHO,2000 被引量：1
7[6]Dye C, Scheele S, Dolin P, et al. Global burden of tuberculosis:estimated incidence, prevalence, and mortality by country [ J].JAMA, 1999,282 : 677-686 被引量：1
8[7]Isman MD. TB elimination in the 21st century, a quixotic dream? [J] Int J Tuberc Lung Dis, 2000,4(12 Suppl 2):s109-s110 被引量：1
9[9]Fang Z, Doig C, Rayner A, et al. Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland(1990 to 1997)[J]. J Clin Microbiol, 1999,37:998-1003 被引量：1
10[10]Kiepiela P,Bishop KS, Smith AN, et al. Genomic mutations in the katG,inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa[J]. Tuver Lung Dis, 2000, 80:47-56 被引量：1
4World Health Organization.WHO Report "2001 Global Tuberculosis Control"[ R ].Geneva:WHO.2001. 被引量：1
5Alex van Belkum. Tracing isolates of bacterial species by multilocus variable number of tandem repeat analysis [J]. Immunol Med Microbiol, 49 (2007): 22-27. 被引量：1
6DeRiemer K, GarcIa2GarcIa L, Bobadilla2del2Valle M, et al. Does DOTS work in populations with drug2resistant tuberculosis [J]. Lancet, 2005 , 365: 1239-1245. 被引量：1
7Durmaz R, Ozerol IH, DunnazB, et al. Primary drug resistance and molecular ep idemiology of Mycobacterium tuberculosis isolates from patients in a population with high tuberculosis incidence in Turkey[J], Microb Drug Resist, 2003, 9: 361-366. 被引量：1
